UNSPSC 51334207: Quetiapine fumarate

This classification denotes a serotonin antagonist and antipsychotic agent with the molecular formula 2C21H25N3O2S.C4H4O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2S3PL1B6UJ, chemically known as 2-(2-(4-dibenzo(b,f)(1,4)thiazepin-11-yl-1-piperazinyl)ethoxy)ethanol fumarate ( but more generally known as quetiapine fumarate, which bears US NIH Compound Identifier 5002. European Medicines Agency schedules Quetiapine fumarate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB15074MIG.

UNSPSC 51334207 Quetiapine fumarate is a Commodity code, but the recent state and local procurement activity tagged to it does not reflect pharmaceutical procurement for this antipsychotic medication. Instead, the single recent opportunity on record involves Seminole County, Florida procuring naloxone (an opioid antagonist) and drug deactivation systems through competitive bidding — a clear mismatch with the code's nominal scope. The code shows minimal relevant recent activity for quetiapine fumarate procurement in the state and local market.

No substantive state and local solicitations for quetiapine fumarate itself are present in the available opportunities. Seminole County's IFB 60459723LAS (posted June 30, 2026, due July 26, 2023) targets naloxone and safe drug deactivation systems for community health initiatives, not psychiatric pharmaceuticals. Without additional recent opportunities aligned to the code's actual commodity definition, practitioners should treat this code as currently inactive for business development purposes in state and local procurement.